Share on StockTwits
 

athenahealth (NASDAQ:ATHN) announced its earnings results on Thursday. The company reported $0.57 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.45 by $0.12, Analyst Ratings Network.com reports. The company had revenue of $171.60 million for the quarter, compared to the consensus estimate of $168.39 million.

In other athenahealth news, SVP Daniel Orenstein unloaded 1,000 shares of the company’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $146.73, for a total transaction of $146,730.00. Following the completion of the sale, the senior vice president now directly owns 31,262 shares of the company’s stock, valued at approximately $4,587,073. The sale was disclosed in a legal filing with the SEC, which is available at this link.

athenahealth (NASDAQ:ATHN) traded down 1.72% on Thursday, hitting $139.08. The stock had a trading volume of 1,152,362 shares. athenahealth has a 52 week low of $82.01 and a 52 week high of $148.55. The stock has a 50-day moving average of $136.5 and a 200-day moving average of $123.7. The company’s market cap is $5.169 billion.

A number of analysts have recently weighed in on ATHN shares. Analysts at Raymond James upgraded shares of athenahealth from an “outperform” rating to a “strong-buy” rating in a research note to investors on Friday, December 13th. They now have a $150.00 price target on the stock. On the ratings front, analysts at Leerink Swann upgraded shares of athenahealth from a “market perform” rating to an “outperform” rating in a research note to investors on Friday, December 13th. They now have a $150.00 price target on the stock. Finally, analysts at ISI Group raised their price target on shares of athenahealth from $126.00 to $133.00 in a research note to investors on Friday, December 13th. They now have a “neutral” rating on the stock. Three research analysts have rated the stock with a sell rating, nine have given a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Hold” and an average target price of $137.53.

athenahealth, Inc (NASDAQ:ATHN), is a business services company, which provides ongoing billing, clinical-related, and other related services to its customers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.